Johnson & Johnson at center of first opioid crisis trial
Our live coverage has ended. Scroll through the posts below to see how the opening statements unfolded, and read more about the trial here.
Opening arguments in the Oklahoma opioid trial just ended.
Larry Ottaway, an attorney representing Johnson & Johnson and its subsidiary company, Janssen Pharmaceuticals, defended his client's conduct.
“Janssen’s conduct was not a nuisance. They provided medically necessary mediations…. They were lawfully subscribed by doctors in the state of Oklahoma.
Total documented cases of addictions or death due to one of the Janssen’s medication in this case? Zero, Ottaway says.
Still, the state of Oklahoma wants Johnson & Johnson to pay $17.5 billion, Ottaway says.
That would go for, among other things, universal screenings for all Medicaid patients 30 times a year for substance abuse.
The state wants Janssen to pay for a needle exchange program – but the company never made an opioid you needed a syringe for, he said.
Larry Ottaway, a defense lawyer representing Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, just cited a DCD report in his opening statement.
The report says: “Public health interventions to reduce prescription drug addiction must strike a balance between reducing misuse and abuse and safeguarding legitimate access to treatment.”
He asked those in the courtroom to think about what it would be like if pain "never went away."
“When we talk about the balance between risk of addiction and unrelenting pain, that is the balance the government is speaking about,” Ottaway said.
There are 50 million adults with chronic pain, he said citing CDC data.
“Janssen did not invent this disease,” he said, but is trying to treat pain.
The trial Oklahoma Johnson & Johnson trial has resumed.
The Norman, Oklahoma court room is at capacity, and two television cameras operated by the Courtroom View Network are sharing images of the trial with other media.
Judge Thad Balkman is allowing the defense to continue making opening statements.
Earlier today, the State of Oklahoma, in its opening statements, accused Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, of fueling the opioid epidemic and causing a "public nuisance."
Defense lawyer Larry Ottaway began laying out the case for Johnson & Johnson and its subsidiary Janssen Pharmaceuticals in his opening statement.
He cited John Adam’s famous quote -- “Facts are stubborn things" -- criticized some of the allegations made by Oklahoma, which brought the lawsuit against his clients.
He said that in 2009, when Janssen said opioids were rarely addictive, the Food and Drug Administration also said that opioids “rarely caused addiction.”
The court is now on a lunch break. The defense team will continue its opening statements when they return at 1:30 p.m.
Attorney Michael Burrage just concluded the opening statement for the State of Oklahoma.
He cited the book, “All I really need to know I learned in Kindergarten,” and said Johnson & Johnson should be responsible for cleaning up their own messes.
What happens next: Attorneys for Johnson & Johnson and its subsidiary company, Janssen Pharmaceuticals will begin their opening statements after a 20-minute recess.
Brad Beckworth, a private attorney hired by the State of Oklahoma, said Johnson & Johnson “aggressively” marketed its products to anyone and everyone.
He also broke down some of the numbers behind the opioid crisis in Oklahoma:
- 135 opioid pills were available for every adult in Cleveland County, Oklahoma — where the trial is being held.
- 139,359 years of life were lost as a result of overdose deaths of prescription opioids, Beckworth said.
- There were 149,183 sales visits made to doctors in the state of Oklahoma between 1999 and 2005, he told the judge.